Literature DB >> 15388659

Method for measurement of peroxisomal very-long-chain fatty acid beta-oxidation in human skin fibroblasts using stable-isotope-labeled tetracosanoic acid.

Stephan Kemp1, Fredoen Valianpour, Petra A W Mooyer, Willem Kulik, Ronald J A Wanders.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15388659     DOI： 10.1373/clinchem.2004.038539

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  12 in total

1.  Human fatty acid transport protein 2a/very long chain acyl-CoA synthetase 1 (FATP2a/Acsvl1) has a preference in mediating the channeling of exogenous n-3 fatty acids into phosphatidylinositol.

Authors:  Elaina M Melton; Ronald L Cerny; Paul A Watkins; Concetta C DiRusso; Paul N Black
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

Review 2.  X-linked adrenoleukodystrophy: pathogenesis and treatment.

Authors:  Marc Engelen; Stephan Kemp; Bwee-Tien Poll-The
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

Review 3.  The peroxisomal ABC transporter family.

Authors:  Ronald J A Wanders; Wouter F Visser; Carlo W T van Roermund; Stephan Kemp; Hans R Waterham
Journal:  Pflugers Arch       Date:  2006-10-13       Impact factor: 3.657

4.  Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy.

Authors:  Quentin Raas; Malu-Clair van de Beek; Sonja Forss-Petter; Inge Me Dijkstra; Abigail Deschiffart; Briana C Freshner; Tamara J Stevenson; Yorrick Rj Jaspers; Liselotte Nagtzaam; Ronald Ja Wanders; Michel van Weeghel; Joo-Yeon Engelen-Lee; Marc Engelen; Florian Eichler; Johannes Berger; Joshua L Bonkowsky; Stephan Kemp
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

Review 5.  Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.

Authors:  Stephan Kemp; Irene C Huffnagel; Gabor E Linthorst; Ronald J Wanders; Marc Engelen
Journal:  Nat Rev Endocrinol       Date:  2016-06-17       Impact factor: 43.330

6.  X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.

Authors:  Marc Engelen; Stephan Kemp; Marianne de Visser; Björn M van Geel; Ronald J A Wanders; Patrick Aubourg; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2012-08-13       Impact factor: 4.123

7.  Arginine improves peroxisome functioning in cells from patients with a mild peroxisome biogenesis disorder.

Authors:  Kevin Berendse; Merel S Ebberink; Lodewijk Ijlst; Bwee Tien Poll-The; Ronald J A Wanders; Hans R Waterham
Journal:  Orphanet J Rare Dis       Date:  2013-09-09       Impact factor: 4.123

8.  An ABCD1 Mutation (c.253dupC) Caused Diverse Phenotypes of Adrenoleukodystrophy in an Iranian Consanguineous Pedigree.

Authors:  Masoud Mehrpour; Faeze Gohari; Majid Zaki Dizaji; Ali Ahani; May Christine V Malicdan; Babak Behnam
Journal:  J Mol Genet Med       Date:  2016-06-19

9.  X-linked adrenoleukodystrophy: molecular and functional analysis of the ABCD1 gene in Argentinean patients.

Authors:  Cyntia Anabel Amorosi; Helena Myskóva; Mariela Roxana Monti; Carlos Enrique Argaraña; Masashi Morita; Stephan Kemp; Raquel Dodelson de Kremer; Lenka Dvoráková; Ana María Oller de Ramírez
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

10.  C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man.

Authors:  Malu-Clair van de Beek; Inge M E Dijkstra; Henk van Lenthe; Rob Ofman; Dalia Goldhaber-Pasillas; Nicolas Schauer; Martin Schackmann; Joo-Yeon Engelen-Lee; Frédéric M Vaz; Wim Kulik; Ronald J A Wanders; Marc Engelen; Stephan Kemp
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.